Correlation Between Algorand and United Therapeutics

Can any of the company-specific risk be diversified away by investing in both Algorand and United Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Algorand and United Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Algorand and United Therapeutics, you can compare the effects of market volatilities on Algorand and United Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Algorand with a short position of United Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Algorand and United Therapeutics.

Diversification Opportunities for Algorand and United Therapeutics

0.75

Correlation Coefficient

Algorand  United Therapeutics

Poor diversification

The 3 months correlation between Algorand and United is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Algorand and United Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Therapeutics and Algorand is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Algorand are associated (or correlated) with United Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Therapeutics has no effect on the direction of Algorand i.e., Algorand and United Therapeutics go up and down completely randomly.

Pair Corralation between Algorand and United Therapeutics

Assuming the 90 days trading horizon Algorand is expected to under-perform the United Therapeutics. In addition to that, Algorand is 2.56 times more volatile than United Therapeutics. It trades about -0.15 of its total potential returns per unit of risk. United Therapeutics is currently generating about -0.1 per unit of volatility. If you would invest  34,550  in United Therapeutics on December 22, 2024 and sell it today you would lose (5,400) from holding United Therapeutics or give up 15.63% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	93.75%
Values	Daily Returns

Algorand  vs.  United Therapeutics

Algorand

Risk-Adjusted Performance

Very Weak

Over the last 90 days Algorand has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Crypto's fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for Algorand shareholders.

United Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days United Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Algorand and United Therapeutics

The main advantage of trading using opposite Algorand and United Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Algorand position performs unexpectedly, United Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will offset losses from the drop in United Therapeutics' long position.

The idea behind Algorand and United Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.